| P50 | author | John A Kellum | Q88345864 |
| P2093 | author name string | Norbert Lameire | |
| | KDIGO AKI Guideline Work Group | |
| P2860 | cites work | Dialysis Disequilibrium Syndrome: brain death following hemodialysis for metabolic acidosis and acute renal failure--a case report | Q21261412 |
| | Biocompatible hemodialysis membranes for acute renal failure | Q24242549 |
| | Intermittent versus continuous renal replacement therapy for acute renal failure in adults | Q24244242 |
| | Grading quality of evidence and strength of recommendations | Q24562409 |
| | Intensity of renal support in critically ill patients with acute kidney injury | Q24647264 |
| | Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma | Q24673070 |
| | Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis | Q28252487 |
| | Renal replacement therapy in patients with acute renal failure: a systematic review | Q28269259 |
| | A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation | Q28285964 |
| | A mechanistic analysis of the National Cooperative Dialysis Study (NCDS) | Q28307354 |
| | Ultrasonic locating devices for central venous cannulation: meta-analysis | Q30478669 |
| | Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy | Q33320267 |
| | A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration | Q33330478 |
| | Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia | Q33346149 |
| | Essentials of anticoagulation in hemodialysis | Q33374743 |
| | Anticoagulation options for patients with heparin-induced thrombocytopenia requiring renal support in the intensive care unit | Q33375037 |
| | Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Q33380060 |
| | Citrate anticoagulation for continuous venovenous hemofiltration | Q33382598 |
| | Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials | Q33394146 |
| | Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials | Q33435406 |
| | Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis | Q33497692 |
| | Outcome in children receiving continuous venovenous hemofiltration | Q33949656 |
| | Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry | Q34090460 |
| | Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study | Q34287116 |
| | Hospital-acquired renal insufficiency | Q34522737 |
| | Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. | Q52943107 |
| | Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. | Q53328588 |
| | Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. | Q53589461 |
| | Guidelines for the Prevention of Intravascular Catheter–Related Infections | Q59586619 |
| | Continuous renal replacement therapy: A worldwide practice survey | Q61661852 |
| | Agranulocytosis in a haemodialysed patient induced by a proteinase inhibitor, nafamostate mesilate | Q67504942 |
| | Dosing of contrast material to prevent contrast nephropathy in patients with renal disease | Q69623920 |
| | Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications | Q70249762 |
| | Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy | Q70589184 |
| | Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media | Q70761074 |
| | Epidemiology of sepsis and multiple organ dysfunction syndrome in children | Q71089635 |
| | N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock | Q71255358 |
| | Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage | Q71534434 |
| | Continuous renal replacement therapy in critically ill patients: monitoring circuit function | Q71665633 |
| | Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group | Q71690220 |
| | Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure | Q71703194 |
| | Anaphylactoid reaction induced by nafamostat mesilate in a hemodialysis patient | Q71728943 |
| | Anticoagulation with nafamostat mesilate, a synthetic protease inhibitor, in hemodialysis patients with a bleeding risk | Q72693925 |
| | Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding | Q72857166 |
| | Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction | Q73024391 |
| | Access recirculation in temporary hemodialysis catheters as measured by the saline dilution technique | Q73235643 |
| | Enhanced blood coagulation and enhanced fibrinolysis during hemodialysis with prostacyclin | Q74397172 |
| | Measurement of the delivery of dialysis in acute renal failure | Q77317334 |
| | Prescribed versus delivered dialysis in acute renal failure patients | Q77573621 |
| | PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction | Q77745729 |
| | Section V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system | Q78390922 |
| | Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients | Q79398671 |
| | Renal recovery after severe acute renal failure | Q79424753 |
| | Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease | Q80465437 |
| | Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study | Q80467279 |
| | Disease severity adversely affects delivery of dialysis in acute renal failure | Q81535612 |
| | Strategies to prevent central line-associated bloodstream infections in acute care hospitals | Q82229558 |
| | The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm | Q83138025 |
| | Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial | Q44643934 |
| | Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study | Q44644452 |
| | Fluid overload and acute renal failure in pediatric stem cell transplant patients | Q44666993 |
| | Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. | Q45923632 |
| | Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. | Q45961395 |
| | Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chroni | Q46000107 |
| | Background fluctuation of kidney function versus contrast-induced nephrotoxicity | Q46113828 |
| | The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit | Q46121477 |
| | Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial | Q46180024 |
| | A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention | Q46236489 |
| | Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial | Q46389817 |
| | Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis | Q46400751 |
| | Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. | Q46480471 |
| | Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention | Q46528225 |
| | A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDF. | Q46676804 |
| | Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients | Q46689751 |
| | Clinical evaluation of hemofiltration without anticoagulation in critically ill patients at high risk of bleeding | Q46872622 |
| | Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min | Q46879094 |
| | Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding | Q46965035 |
| | Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis | Q48140830 |
| | Intracranial pressure fluctuation during hemodialysis in renal failure patients with intracranial hemorrhage. | Q49054897 |
| | Blood recirculation in temporary central catheters for acute hemodialysis | Q50105338 |
| | Real-time ultrasonographically-guided internal jugular vein catheterization in the emergency department increases success rates and reduces complications: a randomized, prospective study | Q50191373 |
| | Clinical practice guidelines for vascular access. | Q51170270 |
| | Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration. | Q51620662 |
| | A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration. | Q51752449 |
| | Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. | Q51908165 |
| | Iloprost for additional anticoagulation in continuous renal replacement therapy--a pilot study. | Q52926135 |
| | Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy | Q34613433 |
| | Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. | Q34681609 |
| | Acute kidney failure: a pediatric experience over 20 years | Q34799311 |
| | Intensity of continuous renal-replacement therapy in critically ill patients | Q35008962 |
| | Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients | Q35629875 |
| | Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis | Q35852237 |
| | Effect of fluid overload and dose of replacement fluid on survival in hemofiltration | Q35934371 |
| | Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials | Q35972979 |
| | Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. | Q36032994 |
| | Dialysis and iodinated contrast media | Q36448304 |
| | Baseline renal function screening | Q36584075 |
| | epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England | Q36738967 |
| | Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis | Q37063979 |
| | Contrast-induced acute kidney injury | Q37134762 |
| | The role of extracorporeal blood purification therapies in the prevention of radiocontrast-induced nephropathy. | Q37210133 |
| | Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis | Q37332528 |
| | Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis | Q37362282 |
| | Current status of gadolinium toxicity in patients with kidney disease | Q37388257 |
| | Outcomes of critically ill children requiring continuous renal replacement therapy | Q37425538 |
| | Continuous renal replacement therapies in patients with acute neurological injury | Q37475100 |
| | Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis | Q37585848 |
| | Back to the future: extended dialysis for treatment of acute kidney injury in the intensive care unit. | Q37790333 |
| | Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). | Q40284634 |
| | Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography | Q40421742 |
| | Timing and predictors of death in pediatric patients with multiple organ system failure. | Q40763759 |
| | Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity. | Q40801877 |
| | Mechanisms of hyperkalemia caused by nafamostat mesilate | Q41068305 |
| | Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature | Q41270670 |
| | Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy | Q41459924 |
| | Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury | Q42165748 |
| | Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients | Q42634934 |
| | Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures | Q43255737 |
| | Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage | Q43265108 |
| | Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study | Q43299538 |
| | Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. | Q43783998 |
| | Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful | Q43826447 |
| | Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent | Q44005393 |
| | Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial | Q44025004 |
| | Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy | Q44200953 |
| | Daily hemodialysis and the outcome of acute renal failure | Q44215628 |
| | Nephrotoxic effects in high-risk patients undergoing angiography | Q44305026 |
| | Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial. | Q44394953 |
| P433 | issue | 1 | |
| P921 | main subject | acute kidney injury | Q424337 |
| | contrast agent | Q6849688 |
| P304 | page(s) | 205 | |
| P577 | publication date | 2013-02-04 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). | |
| P478 | volume | 17 | |